About Xentech
Xentech is a company based in Paris (France) founded in 2006.. Xentech has raised $765 thousand across 2 funding rounds from investors including European Union and Aurinvest. Xentech offers products and services including PDX Models, CDX Models, and In Vivo Services. Xentech operates in a competitive market with competitors including Certis Oncology Solutions, Yecuris, zPREDICTA, Chengdu Zhongke Aoge Biotechnology and Sagres Discovery, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$765 K (USD)
in 2 rounds
-
Latest Funding Round
$162.9 K (USD), Grant
Jan 01, 2016
-
Investors
European Union
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xentech
Xentech offers a comprehensive portfolio of products and services, including PDX Models, CDX Models, and In Vivo Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Human tumor-based models for preclinical drug testing and profiling
Cell-derived models for immuno-oncology research applications
Services for in vivo experiments in drug development
Funding Insights of Xentech
Xentech has successfully raised a total of $765K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $162.9 thousand completed in January 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $162,900
-
First Round
First Round
(12 Nov 2008)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2016 | Amount | Grant - Xentech | Valuation |
investors |
|
| Nov, 2008 | Amount | Seed - Xentech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Xentech
Xentech has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Aurinvest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Xentech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Xentech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Xentech Comparisons
Competitors of Xentech
Xentech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Certis Oncology Solutions, Yecuris, zPREDICTA, Chengdu Zhongke Aoge Biotechnology and Sagres Discovery, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Oncology-based in-vivo drug development services are provided.
|
|
| domain | founded_year | HQ Location |
Humanized liver rodent models are developed for biology research.
|
|
| domain | founded_year | HQ Location |
Tumor-specific in vitro 3D models are supplied for drug development.
|
|
| domain | founded_year | HQ Location |
Xenotransplantation technology for human-compatible organs is developed.
|
|
| domain | founded_year | HQ Location |
Creates innovative mouse models to analyze genes causing cancer diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Xentech
When was Xentech founded?
Xentech was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Where is Xentech located?
Xentech is headquartered in Paris, France.
Is Xentech a funded company?
Xentech is a funded company, having raised a total of $765K across 2 funding rounds to date. The company's 1st funding round was a Seed of $765K, raised on Nov 12, 2008.
What does Xentech do?
Xentech was established in 2006 as a spin-off from Institut Curie in Paris, France, focusing on oncology research. A collection of patient-derived xenograft models is maintained, supporting translational drug development through fee-for-service contracts. Preclinical studies in collaboration with biopharma and academic partners are conducted, with emphasis on breast cancer models. Operations center on addressing needs in early-stage cancer therapeutics.
Who are the top competitors of Xentech?
Xentech's top competitors include Certis Oncology Solutions, Yecuris and zPREDICTA.
What products or services does Xentech offer?
Xentech offers PDX Models, CDX Models, and In Vivo Services.
Who are Xentech's investors?
Xentech has 2 investors. Key investors include European Union, and Aurinvest.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.